Publications by authors named "F Guffanti"

Claim this Profile
O
Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian Carcinomas.
Federica Guffanti, Ilaria Mengoli, Francesca Ricci, Ludovica Perotti, Elena Capellini

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring.
Michele Tomanelli, Federica Guffanti, Giulia Vargiu, Edoardo Micotti, Mara Rigamonti

Front Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches.
Federica Guffanti, Ilaria Mengoli, Giovanna Damia

Front Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.
Michela Chiappa, Alessandra Decio, Luca Guarrera, Ilaria Mengoli, Anju Karki, Federica Guffanti

Cell Death Dis· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models.
Federica Guffanti, Ilaria Mengoli, Maria Francesca Alvisi, Giulia Dellavedova, Raffaella Giavazzi

Front Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis